Lorazepam in anxiety with GI disorders.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000150:complications / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications*; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use*; D008297:Male
D014151:Anti-Anxiety Agents; D008140:Lorazepam